Supernus Pharmaceuticals Inc (SUPN)
36.57
+0.17
(+0.47%)
USD |
NASDAQ |
Nov 08, 16:00
36.57
0.00 (0.00%)
After-Hours: 20:00
Supernus Pharmaceuticals Revenue (Annual): 607.52M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 607.52M |
| December 31, 2022 | 667.24M |
| December 31, 2021 | 579.78M |
| December 31, 2020 | 520.40M |
| December 31, 2019 | 392.76M |
| December 31, 2018 | 408.90M |
| December 31, 2017 | 302.24M |
| December 31, 2016 | 215.00M |
| December 31, 2015 | 147.46M |
| Date | Value |
|---|---|
| December 31, 2014 | 92.68M |
| December 31, 2013 | 12.02M |
| December 31, 2012 | 1.48M |
| December 31, 2011 | 0.803M |
| December 31, 2010 | 0.106M |
| December 31, 2009 | 37.92M |
| December 31, 2008 | 8.889M |
| December 31, 2007 | 4.233M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
392.76M
Minimum
2019
667.24M
Maximum
2022
553.54M
Average
579.78M
Median
2021
Revenue (Annual) Benchmarks
| ACADIA Pharmaceuticals Inc | 726.44M |
| Regeneron Pharmaceuticals Inc | 13.12B |
| United Therapeutics Corp | 2.328B |
| Ligand Pharmaceuticals Inc | 131.31M |
| Myomo Inc | 19.24M |